📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Adello Biologics

1.1 - Company Overview

Adello Biologics Logo

Adello Biologics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of high-quality, affordable biosimilars, leveraging science-led innovation to accelerate development and drive manufacturing efficiency for patients worldwide; headquartered in Piscataway, NJ and led by industry veterans.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Adello Biologics

Rexahn Pharmaceuticals Logo

Rexahn Pharmaceuticals

HQ: United States Website
  • Description: Provider of treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rexahn Pharmaceuticals company profile →
Redx Pharma Logo

Redx Pharma

HQ: United Kingdom Website
  • Description: Provider of drug discovery and development advancing clinical-stage assets Zelasudil (ROCK2 inhibitor for idiopathic pulmonary fibrosis and fibrotic diseases), Zamaporvint (Porcupine inhibitor for Wnt-ligand driven cancer), RXC008 (GI-targeted pan-ROCK for fibrostenotic Crohn's), and a Drug Discovery Engine supporting programs in fibrosis and oncology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Redx Pharma company profile →
BioXcel Therapeutics Logo

BioXcel Therapeutics

HQ: United States Website
  • Description: Provider of AI-driven drug re-innovation and therapeutics, including IGALMI, an FDA-approved sublingual film for acute agitation in adults with schizophrenia or bipolar I/II; BXCL501, an investigational dissolving dexmedetomidine film for agitation related to Alzheimer’s dementia and bipolar or schizophrenia; BXCL701, an oral innate immune activator under investigation for aggressive prostate, pancreatic, and other solid and liquid tumors; plus an Expanded Access Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioXcel Therapeutics company profile →
Restorbio Logo

Restorbio

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapeutics, focused on developing and commercializing novel treatments, including RTB101, a TORC1 inhibitor for aging-related diseases such as Parkinson’s disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Restorbio company profile →
Polichem Logo

Polichem

HQ: Switzerland Website
  • Description: Provider of tools and knowledge to improve the health of patients worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Polichem company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Adello Biologics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Adello Biologics

2.2 - Growth funds investing in similar companies to Adello Biologics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Adello Biologics

4.2 - Public trading comparable groups for Adello Biologics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Adello Biologics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Adello Biologics

What does Adello Biologics do?

Adello Biologics is a provider of high-quality, affordable biosimilars, leveraging science-led innovation to accelerate development and drive manufacturing efficiency for patients worldwide; headquartered in Piscataway, NJ and led by industry veterans.

Who are Adello Biologics's competitors?

Adello Biologics's competitors and similar companies include Rexahn Pharmaceuticals, Redx Pharma, BioXcel Therapeutics, Restorbio, and Polichem.

Where is Adello Biologics headquartered?

Adello Biologics is headquartered in United States.

How many employees does Adello Biologics have?

Adello Biologics has 1,000 employees 🔒.

When was Adello Biologics founded?

Adello Biologics was founded in 2010 🔒.

What sector and industry vertical is Adello Biologics in?

Adello Biologics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Adello Biologics

Who are the top strategic acquirers in Adello Biologics's sector and industry

Top strategic M&A buyers and acquirers in Adello Biologics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Adello Biologics?

Top strategic M&A buyers groups and sectors for Adello Biologics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Adello Biologics's sector and industry vertical

Which are the top PE firms investing in Adello Biologics's sector and industry vertical?

Top PE firms investing in Adello Biologics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Adello Biologics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Adello Biologics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Adello Biologics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Adello Biologics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Adello Biologics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Adello Biologics?

The key public trading comparables and valuation benchmarks for Adello Biologics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Adello Biologics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Adello Biologics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Adello Biologics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Adello Biologics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Adello Biologics's' sector and industry vertical?

Access recent funding rounds and capital raises in Adello Biologics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Adello Biologics